Chronic kidney disease is growing at an alarming rate, and often, people have no idea they’re living with it. For that reason ...

For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments. More than ...

PKD is mainly caused by mutations in the PKD1 and PKD2 genes, affecting polycystin proteins. Disrupted signaling pathways, like cAMP and vasopressin, are major drivers of cyst growth. Tolvaptan is ...

Experts recently developed 23 consensus practice points/statements regarding the use of nephrectomy in autosomal dominant polycystic kidney disease (ADPKD). Regardless of when it was performed in ...

Nine out of 10 people with chronic kidney disease only find out when it progresses to later stages. Here’s what we know about its risk factors—and why there's new reason to hope for more effective ...

Liver cysts were found in over 80% of patients with ADPKD but were not associated with chronic kidney disease stage, Mayo classification, PKD1 or PKD2 genotype variant, liver enzyme levels, or quality ...

Chronic kidney disease (CKD) affects more than 700 million people worldwide and is caused by genetic and environmental ...

Renasant Bio has launched with $54.5 million in seed financing to develop treatments for autosomal dominant polycystic kidney disease (ADPKD), which causes severe kidney damage. The financing was led ...

Kidney disease doctor Mohamed Ibrahim and transplant recipient Larry Jones join Jennifer Franciotti to talk about the National Kidney Foundation's Maryland Kidney Walk.

MONMOUTH, N.J., Sept. 18, 2025 /PRNewswire/ -- J & D Pharmaceuticals LLC has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company's ...